117 related articles for article (PubMed ID: 37640002)
41. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
[TBL] [Abstract][Full Text] [Related]
42. LncRNA LINC00152 promotes oral squamous cell carcinoma growth via enhancing Upstream Transcription Factor 1 mediated Mitochondrial Ribosomal Protein L52 transcription.
Zou X; Hu X; He F; Zhang M; Kong X; Rui S; Liu Y; Wang L; Zheng X; Liu J; Li Z; Luo H
J Oral Pathol Med; 2022 May; 51(5):454-463. PubMed ID: 34664331
[TBL] [Abstract][Full Text] [Related]
43. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
Wang C; Wang Q; Weng Z
Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
[TBL] [Abstract][Full Text] [Related]
44. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
46. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
[TBL] [Abstract][Full Text] [Related]
47. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
48. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
[TBL] [Abstract][Full Text] [Related]
49. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
50. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
Yao Y; Liu Y; Jin F; Meng Z
Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
[TBL] [Abstract][Full Text] [Related]
51. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
[TBL] [Abstract][Full Text] [Related]
52. Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma.
Zhang X; Geng L; Tang Y; Wang Y; Zhang Y; Zhu C; Lei H; Xu H; Zhu Q; Wu Y; Gu W
J Transl Med; 2024 Feb; 22(1):193. PubMed ID: 38388430
[TBL] [Abstract][Full Text] [Related]
53.
Wen Z; Zhang Y; Wang X; Wu Y; Mao J; Li Q; Gong S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686118
[TBL] [Abstract][Full Text] [Related]
54. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
[TBL] [Abstract][Full Text] [Related]
55. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
56. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
57. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
Dai Y; Zhu Y; Xu H
J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
[TBL] [Abstract][Full Text] [Related]
58. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
59. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
60. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
